Mild to moderate stroke recovery study
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a daily supplement called NeuroAiD to see if it helps people recover after a mild or moderate stroke. It looks at how well patients feel and function in their daily life during recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a mild or moderate ischemic stroke (a stroke caused by a blocked blood vessel) within the last 2 to 10 days.
- You are stable and your doctor thinks you can take part in active rehabilitation (therapy to improve recovery).
- You have not used certain stroke medications (like Cerebrolysin, piracetam, or edaravone) in the past 30 days.
- You are not pregnant, breastfeeding, or using hormone replacement therapy.
- You are not allergic to any ingredient in NeuroAiD.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an herbal medicine (MLC1501) to see if it helps people recover better after a stroke. If you join, you'll take the medicine or a placebo (a pill with no active ingredient) while doing rehabilitation, and the study will track your recovery over time.
This study looks at how people recover after a stroke. Researchers will check your thinking, memory, and daily function over a year to learn more about recovery patterns and help design better treatments.
This study looks at how your immune system reacts to stroke treatments like clot-busting drugs or mechanical clot removal. The goal is to see if immune markers can predict recovery, which could help tailor future stroke care.
This trial tests whether an investigational study drug can improve outcomes after an acute ischemic stroke (a stroke caused by blocked blood flow). You may be eligible if you are able to start treatment quickly after symptom onset and have a moderate stroke severity on a standard stroke exam.
This study tests two medications, isosorbide mononitrate and butylphthalide, to see if taking them early after a small type of stroke (called lacunar) can reduce the chances of long-term disability. You would receive one of these medications or a placebo, and the study will follow your recovery over time.
This trial tests an experimental drug given by IV to help people recover arm and leg movement after a severe stroke. It may help improve recovery in the early weeks after a stroke.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.